ValiRx PLC - ESG Rating & Company Profile powered by AI
Complete Sustainability assessment of ValiRx PLC are accessed by logging in. The Sustainability score for ValiRx PLC indicates the company's transparency towards the UN Sustainable Development Goals. Alternative corporations in the rating peer group for ValiRx PLC are displayed below.
ValiRx PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 2.7, social score of 8.0 and governance score of 5.3.
5.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 886 | Veracyte Inc | 5.4 | High |
| 886 | Xlife Sciences AG | 5.4 | High |
| 912 | ValiRx PLC | 5.3 | High |
| 912 | Acer Therapeutics Inc | 5.3 | High |
| 912 | Alembic Pharmaceuticals Ltd | 5.3 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does ValiRx PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes ValiRx PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes ValiRx PLC report the average age of the workforce?
Sign up for free to unlockDoes ValiRx PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes ValiRx PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes ValiRx PLC disclose cybersecurity risks?
Sign up for free to unlockDoes ValiRx PLC offer flexible work?
Sign up for free to unlockDoes ValiRx PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes ValiRx PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes ValiRx PLC conduct supply chain audits?
Sign up for free to unlockDoes ValiRx PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes ValiRx PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes ValiRx PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes ValiRx PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes ValiRx PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes ValiRx PLC disclose water use targets?
Sign up for free to unlockDoes ValiRx PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid ValiRx PLC have a product recall in the last two years?
Sign up for free to unlockDoes ValiRx PLC disclose incidents of discrimination?
Sign up for free to unlockDoes ValiRx PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas ValiRx PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes ValiRx PLC disclose parental leave metrics?
Sign up for free to unlockDoes ValiRx PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes ValiRx PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes ValiRx PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes ValiRx PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes ValiRx PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes ValiRx PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs ValiRx PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes ValiRx PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes ValiRx PLC disclose its waste policy?
Sign up for free to unlockDoes ValiRx PLC report according to TCFD requirements?
Sign up for free to unlockDoes ValiRx PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes ValiRx PLC disclose energy use targets?
Sign up for free to unlockDoes ValiRx PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes ValiRx PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for ValiRx PLC
These potential risks are based on the size, segment and geographies of the company.
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise VAL301, a peptide ingredient that in pre-clinical development for the treatment of women with endometriosis; and BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19. ValiRx plc was incorporated in 2000 and is based in Hatfield, the United Kingdom.